Thursday, June 25, 2026

HomeBusiness NewsVeradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3...

Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01…

- Advertisement -

NEW HAVEN, Conn.–(BUSINESS WIRE)–Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced it will host an investor call and live webcast to review topline results…


Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed